We are already revenue-generating. These projections begin January 2026 and run through December 2028, outlining investment paths from bootstrapped to $40M to scale our multi-specialty AI scribe toward an integrated EHR and medical-native AI stack.
Nov 2024 -> Dec 2025: From concept to live product with organic traction.
Idea conceived for a medical-native AI stack. Initial planning and early model research and fine-tuning.
First developer onboarded; MVP build starts focused on real-time clinical documentation.
Completed first internally fine-tuned medical model optimised for high-speed documentation.
Beta testing with early users; iterative bug fixes and UX improvements based on clinician feedback.
MVP launched on iOS & Android. Zero marketing spend - users found it organically; ongoing iteration.
Phase 2 specifications prepared for multi-specialty and multilingual expansion. CE/UKCA groundwork begins.
ClinixQM quality management platform goes live at clinixqm.gacrux.ai. Beginning of the 36-month roadmap with validated product-market fit, two live products, and first paying clinicians.
Compare funding scenarios from Jan 2026 to Dec 2028. The baseline ($0) is always shown. Use the sliders to explore different investment levels.
Projections from January 2026 to December 2028. Toggle between MRR and ARR views.
Note: MRR and ARR values are approximate. Operating results shown are monthly profit or burn at each time point, not annual.
Our ultimate vision is to build a tightly integrated EHR layer and a medical-native AI stack. The pace varies by investment scenario.
All three paths begin with a revenue-generating product. Your investment determines how quickly we scale, build the EHR platform, and develop the GacruxAI stack.
Explore our product capabilities, competitive analysis, COGS projections, and why we're building a native AI stack.
View Product & Competitive Analysis